FP7H2020HORIZON
Karolinska Institutet
- Country
- SESweden
- Defence projects
- 0
- Projects, all programmes
- 705
- As coordinator
- 254
- EU contribution (CORDIS)
- EUR 463,574,152
- Active
- 2008 to 2026
Projects
705 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SCHIZTYPEBrain cell type-specific interactions and schizophrenia | H2020 | 2019 | Coordinator | EUR 2,064,414 |
| CARECOMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPE | H2020 | 2019 | Participant | EUR 329,950 |
| Epi4MSTargeting the epigenome: towards a better understanding of disease pathogenesis and novel therapeutic strategies in Multiple Sclerosis | H2020 | 2019 | Coordinator | EUR 1,998,798 |
| NECESSITYNEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | H2020 | 2019 | Participant | EUR 251,250 |
| LifeChampsA Collective Intelligence Platform to Support Cancer Champions | H2020 | 2019 | Participant | EUR 276,280 |
| PREFERABLEProject on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life | H2020 | 2019 | Participant | EUR 439,259 |
| GOLIATHBeating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds | H2020 | 2019 | Participant | EUR 402,500 |
| SAPIENSShaping the social brain through early interactions | H2020 | 2019 | Participant | EUR 281,983 |
| V.A. CureA multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies | H2020 | 2019 | Participant | EUR 281,983 |
| TERMINATORRibosomal frameshifts as a novel mechanism to control RNA turnover in stress | H2020 | 2019 | Coordinator | EUR 191,852 |
| LifeTimeRevolutionizing Healthcare by Tracking and Understanding Human Cells during Disease | H2020 | 2019 | Participant | EUR 2,500 |
| ONCOBIOMEGut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | H2020 | 2019 | Participant | EUR 2,801,954 |
| PCinBCPlasma cell heterogeneity and dynamics in patient tumors | H2020 | 2019 | Coordinator | EUR 203,852 |
| EXPERTEXpanding Platforms for Efficacious mRNA Therapeutics | H2020 | 2019 | Participant | EUR 773,463 |
| EU-OPENSCREEN-DRIVEEnsuring long-term sustainability of excellence in chemical biology within Europe and beyond | H2020 | 2019 | Participant | EUR 22,500 |
| PRECODEPancREatic Cancer OrganoiDs rEsearch Network | H2020 | 2019 | Participant | EUR 281,983 |
| EXHAUSTIONExposure to heat and air pollution in EUrope – cardiopulmonary impacts and benefits of mitigation and adaptation | H2020 | 2019 | Participant | EUR 300,000 |
| ArthritisHealEstablishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis | H2020 | 2019 | Participant | EUR 563,966 |
| MyPalMyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems | H2020 | 2019 | Participant | EUR 206,875 |
| AIMS-2-TRIALSAutism Innovative Medicine Studies – 2 – Trials | H2020 | 2018 | Participant | EUR 1,210,567 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.